Lack of Proteinase 3 Stabilizes Advanced Atherosclerotic Lesions

Almudena Ortega-Gomez; Oliver Soehnlein

doi:10.1055/s-0040-1710316

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2020; 120(06): 994-997
DOI: 10.1055/s-0040-1710316

Letter to the Editor

Georg Thieme Verlag KG Stuttgart · New York

Lack of Proteinase 3 Stabilizes Advanced Atherosclerotic Lesions

Almudena Ortega-Gomez

¹Institute for Cardiovascular Prevention, LMU Munich, Munich, Germany

²DZHK, Partner site Munich Heart Alliance, Munich, Germany

,

Oliver Soehnlein

¹Institute for Cardiovascular Prevention, LMU Munich, Munich, Germany

²DZHK, Partner site Munich Heart Alliance, Munich, Germany

³Department of Physiology and Pharmacology (FyFa), Karolinska Institutet, Stockholm, Sweden

› Author Affiliations

Abstract

Full Text

References

References
1 Silvestre-Roig C, Braster Q, Ortega-Gomez A, Soehnlein O. Neutrophils as regulators of cardiovascular inflammation. Nat Rev Cardiol 2020; (January): 1-14
2 Wen G, An W, Chen J. , et al. Genetic and pharmacologic inhibition of the neutrophil elastase inhibits experimental atherosclerosis. J Am Heart Assoc 2018; 7 (04) e008187
3 Soehnlein O, Ortega-Gómez A, Döring Y, Weber C. Neutrophil-macrophage interplay in atherosclerosis: protease-mediated cytokine processing versus NET release. ThrombHaemost 2015; 114 (04) 866-867
4 Warnatsch A, Ioannou M, Wang Q, Papayannopoulos V. Inflammation. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis. Science 2015; 349 (6245): 316-320
5 Emini Veseli B, Perrotta P, De Meyer GRA. , et al. Animal models of atherosclerosis. Eur J Pharmacol 2017; 816: 3-13
6 Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. ArteriosclerThromb 1994; 14 (01) 133-140
7 Hartwig H, Silvestre-Roig C, Hendrikse J. , et al. Atherosclerotic plaque destabilization in mice: a comparative study. PLoS One 2015; 10 (10) e0141019
8 Ortega-Gomez A, Salvermoser M, Rossaint J. , et al. Cathepsin G controls arterial but not venular myeloid cell recruitment. Circulation 2016; 134 (16) 1176-1188
9 Bentzon JF, Otsuka F, Virmani R, Falk E. Mechanisms of plaque formation and rupture. Circ Res 2014; 114 (12) 1852-1866
10 Pham CTN. Neutrophil serine proteases: specific regulators of inflammation. Nat Rev Immunol 2006; 6 (07) 541-550
11 Kessenbrock K, Dau T, Jenne DE. Tailor-made inflammation: how neutrophil serine proteases modulate the inflammatory response. J Mol Med (Berl) 2011; 89 (01) 23-28
12 Wang J, Sjöberg S, Tang T-T. , et al. Cathepsin G activity lowers plasma LDL and reduces atherosclerosis. BiochimBiophysActa 2014; 1842 (11) 2174-2183
13 Rao NV, Wehner NG, Marshall BC, Gray WR, Gray BH, Hoidal JR. Characterization of proteinase-3 (PR-3), a neutrophil serine proteinase. Structural and functional properties. J BiolChem 1991; 266 (15) 9540-9548
14 Sørensen OE, Follin P, Johnsen AH. , et al. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 2001; 97 (12) 3951-3959
15 Ciornei CD, Tapper H, Bjartell A, Sternby NH, Bodelsson M. Human antimicrobial peptide LL-37 is present in atherosclerotic plaques and induces death of vascular smooth muscle cells: a laboratory study. BMC CardiovascDisord 2006; 6: 49
16 Döring Y, Drechsler M, Wantha S. , et al. Lack of neutrophil-derived CRAMP reduces atherosclerosis in mice. Circ Res 2012; 110 (08) 1052-1056
17 Döring Y, Manthey HD, Drechsler M. , et al. Auto-antigenic protein-DNA complexes stimulate plasmacytoid dendritic cells to promote atherosclerosis. Circulation 2012; 125 (13) 1673-1683
18 Zhang Z, Meng P, Han Y. , et al. Mitochondrial DNA-LL-37 complex promotes atherosclerosis by escaping from autophagic recognition. Immunity 2015; 43 (06) 1137-1147
19 Korkmaz B, Horwitz MS, Jenne DE, Gauthier F. Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases. Pharmacol Rev 2010; 62 (04) 726-759
20 Libby P. Interleukin-1 beta as a target for atherosclerosis therapy: biological basis of CANTOS and beyond. J Am CollCardiol 2017; 70 (18) 2278-2289
21 Korkmaz B, Hajjar E, Kalupov T. , et al. Influence of charge distribution at the active site surface on the substrate specificity of human neutrophil protease 3 and elastase. A kinetic and molecular modeling analysis. J BiolChem 2007; 282 (03) 1989-1997
22 Martin KR, Witko-Sarsat V. Proteinase 3: the odd one out that became an autoantigen. J LeukocBiol 2017; 102 (03) 689-698
23 Vong L, D'Acquisto F, Pederzoli-Ribeil M. , et al. Annexin 1 cleavage in activated neutrophils: a pivotal role for proteinase 3. J BiolChem 2007; 282 (41) 29998-30004
24 Drechsler M, de Jong R, Rossaint J. , et al. Annexin A1 counteracts chemokine-induced arterial myeloid cell recruitment. Circ Res 2015; 116 (05) 827-835
25 Fredman G, Kamaly N, Spolitu S. , et al. Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice. SciTransl Med 2015; 7 (275) 275ra20
26 Loison F, Zhu H, Karatepe K. , et al. Proteinase 3-dependent caspase-3 cleavage modulates neutrophil death and inflammation. J Clin Invest 2014; 124 (10) 4445-4458
27 Millet A, Martin KR, Bonnefoy F. , et al. Proteinase 3 on apoptotic cells disrupts immune silencing in autoimmune vasculitis. J Clin Invest 2015; 125 (11) 4107-4121